HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
WWOX
WW domain containing oxidoreductase
Chromosome 16 Β· 16q23.1-q23.2
NCBI Gene: 51741Ensembl: ENSG00000186153.19HGNC: HGNC:12799UniProt: A0A411HBC7
331PubMed Papers
23Diseases
0Drugs
105Pathogenic Variants
FUNCTIONAL ROLE
Tumor Suppressor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
plasma membranemicrovillusprotein bindingenzyme bindingautosomal recessive spinocerebellar ataxia 12developmental and epileptic encephalopathy, 28undetermined early-onset epileptic encephalopathygenetic developmental and epileptic encephalopathy
✦AI Summary

WWOX (WW domain containing oxidoreductase) is a large tumor suppressor gene spanning over 1.11 Mbp at chromosome 16.1-q23.2, containing the common fragile site FRA16D 1. The gene encodes a 46 kDa protein with 414 amino acids that functions as a putative oxidoreductase and transcription regulator 23. WWOX acts as a tumor suppressor through multiple mechanisms, including transcriptional repression and apoptosis induction, with interactions involving c-Jun, TNF, p53, p73, and other key regulatory proteins 2. The protein plays critical roles in cellular senescence and genome stability maintenance by inducing DNA damage response mechanisms and preventing senescence escape 4. WWOX is essential for normal central nervous system development, with mutations causing seizures, ataxia, developmental delay, and spasticity 5. The gene also regulates metabolic processes, including steroid, cholesterol, and glucose metabolism, with deficiency linked to familial dyslipidemias and metabolic syndrome 67. In cancer, WWOX deletions are frequent in esophageal, stomach, colon, bladder, ovarian, and uterine cancers, correlating with poor prognosis and therapy resistance 1. Recent studies demonstrate WWOX's role in immune regulation, where deficiency promotes immunosuppressive macrophage polarization and reduces sensitivity to immunotherapy in hepatocellular carcinoma 8.

Sources cited
1
WWOX spans over 1.11 Mbp at chr16q23.1-q23.2, contains FRA16D fragile site, and shows frequent deletions in multiple cancer types
PMID: 30350478
2
WWOX encodes a 46 kDa protein with 414 amino acids and acts as tumor suppressor through interactions with c-Jun, TNF, p53, p73
PMID: 18437686
3
WWOX functions as a transcription regulator and plays roles in tumor suppression, apoptosis, and CNS development
PMID: 32389029
4
WWOX is required for cellular senescence induction and genome stability maintenance during DNA damage response
PMID: 37897534
5
WWOX mutations cause neurologic phenotypes including seizures, ataxia, developmental delay, and spasticity
PMID: 25416187
6
WWOX regulates metabolic processes and is linked to familial dyslipidemias, osteopenia, and metabolic syndrome
PMID: 36271927
7
WWOX contains SDR domain involved in steroid metabolism and bone development
PMID: 24520212
8
WWOX deficiency promotes immunosuppressive macrophage polarization and reduces HCC sensitivity to immunotherapy
PMID: 39500530
Disease Associationsβ“˜23
autosomal recessive spinocerebellar ataxia 12Open Targets
0.80Strong
developmental and epileptic encephalopathy, 28Open Targets
0.79Strong
undetermined early-onset epileptic encephalopathyOpen Targets
0.70Strong
genetic developmental and epileptic encephalopathyOpen Targets
0.67Moderate
esophageal cancerOpen Targets
0.56Moderate
infantile spasmsOpen Targets
0.56Moderate
developmental and epileptic encephalopathy, 1Open Targets
0.55Moderate
infantile epileptic-dyskinetic encephalopathyOpen Targets
0.55Moderate
Spasticity - intellectual disability - X-linked epilepsyOpen Targets
0.55Moderate
Rolandic epilepsyOpen Targets
0.45Moderate
self-limited epilepsy with centrotemporal spikesOpen Targets
0.45Moderate
esophageal squamous cell carcinomaOpen Targets
0.43Moderate
Neurodevelopmental delayOpen Targets
0.43Moderate
early infantile epileptic encephalopathy, autosomal recessiveOpen Targets
0.43Moderate
genetic disorderOpen Targets
0.42Moderate
alcohol drinkingOpen Targets
0.41Moderate
46,XY partial gonadal dysgenesisOpen Targets
0.38Weak
cerebellar ataxiaOpen Targets
0.37Weak
developmental and epileptic encephalopathyOpen Targets
0.37Weak
early-infantile DEEOpen Targets
0.37Weak
Developmental and epileptic encephalopathy 28UniProt
Esophageal cancerUniProt
Spinocerebellar ataxia, autosomal recessive, 12UniProt
Pathogenic Variants105
NM_016373.4(WWOX):c.214C>T (p.Gln72Ter)Pathogenic
not provided|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2026β†’ Residue 72
NM_016373.4(WWOX):c.410-1G>APathogenic
not provided|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12
β˜…β˜…β˜†β˜†2026
NM_016373.4(WWOX):c.1110_1119del (p.Leu371fs)Pathogenic
Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 371
NM_016373.4(WWOX):c.183C>G (p.Tyr61Ter)Pathogenic
Developmental and epileptic encephalopathy, 28|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1
β˜…β˜…β˜†β˜†2025β†’ Residue 61
NM_016373.4(WWOX):c.790C>T (p.Arg264Ter)Pathogenic
Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|not provided|Malignant tumor of esophagus;Developmental and epileptic encephalopathy, 28;Autosomal recessive spinocerebellar ataxia 12|Developmental and epileptic encephalopathy, 28|WWOX-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 264
NM_016373.4(WWOX):c.173-1G>CPathogenic
Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|Early Infantile Epileptic Encephalopathy, Autosomal Recessive
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.605_605+3delLikely pathogenic
Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|not provided|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.160C>T (p.Arg54Ter)Pathogenic
Developmental and epileptic encephalopathy, 28|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|WWOX-related diosrder
β˜…β˜…β˜†β˜†2025β†’ Residue 54
NM_016373.4(WWOX):c.1043del (p.Phe348fs)Pathogenic
not provided|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025β†’ Residue 348
NM_016373.4(WWOX):c.689A>C (p.Gln230Pro)Pathogenic
Developmental and epileptic encephalopathy, 28|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|Abnormality of the nervous system|Malignant tumor of esophagus|Early Infantile Epileptic Encephalopathy, Autosomal Recessive|not provided|Autosomal recessive spinocerebellar ataxia 12;Malignant tumor of esophagus;Developmental and epileptic encephalopathy, 28|WWOX-related disorder|Autosomal recessive spinocerebellar ataxia 12
β˜…β˜…β˜†β˜†2025β†’ Residue 230
NM_016373.4(WWOX):c.553_566del (p.Ala185fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 185
NM_016373.4(WWOX):c.173-1G>TPathogenic
Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|not provided
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.107+1G>APathogenic
Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 28|Developmental and epileptic encephalopathy, 1|See cases|West syndrome|not provided|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|WWOX-related disorder|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.605+5G>APathogenic
not provided|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 28|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.1114G>T (p.Gly372Ter)Pathogenic
not provided|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12|See cases|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025β†’ Residue 372
NM_016373.4(WWOX):c.409+1G>CPathogenic
Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2025
NM_016373.4(WWOX):c.255C>G (p.Tyr85Ter)Pathogenic
not provided|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1
β˜…β˜…β˜†β˜†2024β†’ Residue 85
NM_016373.4(WWOX):c.606-1G>APathogenic
Global developmental delay;Brain atrophy;Abnormal facial shape|Developmental and epileptic encephalopathy, 28|Autosomal recessive spinocerebellar ataxia 12;Developmental and epileptic encephalopathy, 1|not provided|WWOX-related disorder|Esophageal squamous cell carcinoma
β˜…β˜…β˜†β˜†2024
NM_016373.4(WWOX):c.183C>A (p.Tyr61Ter)Pathogenic
Epileptic encephalopathy|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2024β†’ Residue 61
NM_016373.4(WWOX):c.321C>A (p.Tyr107Ter)Pathogenic
Abnormality of the nervous system|Developmental and epileptic encephalopathy, 28
β˜…β˜…β˜†β˜†2024β†’ Residue 107
View on ClinVar β†—
Related Genes
TP53Protein interaction100%MAPK8Protein interaction100%ATMProtein interaction100%ERBB4Protein interaction99%DVL1Protein interaction99%TFAP2AProtein interaction99%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
71%
Liver
49%
Ovary
41%
Heart
33%
Lung
22%
Gene Interaction Network
Click a node to explore
WWOXTP53MAPK8ATMERBB4DVL1TFAP2A
PROTEIN STRUCTURE
Preparing viewer…
PDB1WMV Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.82LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.51 [1.24–1.82]
RankingsWhere WWOX stands among ~20K protein-coding genes
  • #991of 20,598
    Most Researched331 Β· top 5%
  • #734of 5,498
    Most Pathogenic Variants105 Β· top quartile
  • #16,666of 17,882
    Most Constrained (LOEUF)1.82
Genes detectedWWOX
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
WWOX, the FRA16D gene: A target of and a contributor to genomic instability.
PMID: 30350478
Genes Chromosomes Cancer Β· 2019
1.00
2
The
PMID: 32389029
Exp Biol Med (Maywood) Β· 2020
0.90
3
WWOX gene and gene product: tumor suppression through specific protein interactions.
PMID: 20146584
Future Oncol Β· 2010
0.88
4
The fragile site WWOX gene and the developing brain.
PMID: 25416187
Exp Biol Med (Maywood) Β· 2015
0.80
5
[Genotype and phenotype of WWOX gene related developmental and epileptic encephalopathy].
PMID: 39039877
Zhonghua Er Ke Za Zhi Β· 2024
0.76